Clinical Trials Directory

Trials / Completed

CompletedNCT02889107

Auditory Rehabilitation in Stroke Patients With Auditory Processing Disorders

Long-term Use Benefits of Personal Frequency-modulated Systems for Speech in Noise Perception in Stroke Patients With Auditory Processing Deficits- 'a Non-randomised

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University College, London · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate long term benefits in speech reception in noise, after daily 10 week use of an assisting listening device (personal frequency-modulates systems) , in non-aphasic stroke patients with auditory processing deficits.

Detailed description

Stroke can affect all levels of the auditory pathway. Approximately one in five stroke survivors report severe difficulties when listening to speech-in-noise, despite normal hearing, attributed to abnormal processing of sounds within the brain, and these individuals are more likely to experience communication difficulties in poor acoustic environments, The patient with significant auditory deficits and functional limitations may require a range of rehabilitation and remediation approaches. Several studies conclusively demonstrate substantial improvements in speech recognition in noise when using personal frequency-modulated (FM) systems. These devices are used to improve speech perception in noise in adults with neurological disorders including stroke with good immediate benefits. However, the long-term benefits of FM systems in stroke patients has not been studies. In this research study the investigators aimed to investigate the long term benefits in speech reception in noise in non-aphasic stroke patients and measure the potential improvement in unaided speech in background noise performance after 10 weeks.

Conditions

Interventions

TypeNameDescription
OTHERpersonal frequency modulated systemspatients used personal frequency modulated systems for at least 4 hours daily for 10 weeks

Timeline

Start date
2013-04-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2016-09-05
Last updated
2016-09-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02889107. Inclusion in this directory is not an endorsement.